• SENSEX 81,592.45
    -318.56 (--0.39%)
  • BANKNIFTY 61,034.10
    -484.40 (--0.79%)
Back

Corporate News

Parmax Pharma confirms no deviation in utilization of Rs 19.28 crore funds
14-Nov-2026, 10:39

Parmax Pharma Limited informed the BSE that it has confirmed no deviation or variation in the utilization of Rs 19,28,19,682 raised through the issuance of equity shares and warrants on a preferential basis, as per Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended September 30, 2026.